Predictive potential of STEAP family for survival, immune microenvironment and therapy response in glioma
- 1 December 2021
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 101 (Pt A) , 108183
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81870984)
- Hebei Provincial Natural Science Foundation (H2018206675)
This publication has 37 references indexed in Scilit:
- STEAP1 protein overexpression is an independent marker for biochemical recurrence in prostate carcinomaHistopathology, 2013
- GSVA: gene set variation analysis for microarray and RNA-Seq dataBMC Bioinformatics, 2013
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- Towards a knowledge-based Human Protein AtlasNature Biotechnology, 2010
- STAMP1 Is Both a Proliferative and an Antiapoptotic Factor in Prostate CancerCancer Research, 2010
- Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future DevelopmentsBrain Pathology, 2009
- In vivoEffects of Vaccination with Six-Transmembrane Epithelial Antigen of the Prostate: A Candidate Antigen for Treating Prostate CancerCancer Research, 2007
- The Steap proteins are metalloreductasesBlood, 2006
- Downregulation of major histocompatibility complex antigens in invading glioma cells: stealth invasion of the brainLaboratory Investigation, 2005
- TSAP6 Facilitates the Secretion of Translationally Controlled Tumor Protein/Histamine-releasing Factor via a Nonclassical PathwayJournal of Biological Chemistry, 2004